The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

Other side effects include injection site reactions, itching, rash, lipodystrophy, weight gain, and swollen hands and feet. The rapid-acting insulin aspart biosimilar joins two prior long-acting ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

Insulin, a hormone made by the pancreas ... Other common side effects may include injection site reactions, itching, rash, lipodystrophy (skin thickening or pitting at the injection site ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin ... while more common AEs include injection site reactions, itching, rash, lipodystrophy, weight gain, and swelling ...

lipodystrophy (skin thickening or pitting at the injection site), weight gain, and swelling of hands and feet. In 2023, Sanofi jumped the bandwagon with the other two insulin U.S. giants to lower ...

Smart insulin pens eliminate the guesswork involved in insulin dosing, providing greater convenience for users. Features such as dose memory, missed-dose alerts, and injection time tracking ... exists ...

Insulin, a hormone made by the pancreas ... Other common side effects may include injection site reactions, itching, rash, lipodystrophy (skin thickening or pitting at the injection site), weight gain ...

Since March 2020, FDA has regulated insulin and a subset of other biological ... Other common side effects may include injection-site reactions, itching, rash, lipodystrophy, weight gain, and ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

skin thickening or pitting at the injection site, weight gain, and swelling of hands and feet. "The FDA has now approved three biosimilar insulin products to treat diabetes," Peter Stein ...